Literature DB >> 28202523

Cancer Stem Cells Regulate Cancer-Associated Fibroblasts via Activation of Hedgehog Signaling in Mammary Gland Tumors.

Giovanni Valenti1, Hazel M Quinn1, Guus J J E Heynen1, Linxiang Lan1, Jane D Holland1, Regina Vogel1, Annika Wulf-Goldenberg2, Walter Birchmeier3.   

Abstract

Many tumors display intracellular heterogeneity with subsets of cancer stem cells (CSC) that sustain tumor growth, recurrence, and therapy resistance. Cancer-associated fibroblasts (CAF) have been shown to support and regulate CSC function. Here, we investigate the interactions between CSCs and CAFs in mammary gland tumors driven by combined activation of Wnt/β-catenin and Hgf/Met signaling in mouse mammary epithelial cells. In this setting, CSCs secrete the Hedgehog ligand SHH, which regulate CAFs via paracrine activation of Hedgehog signaling. CAFs subsequently secrete factors that promote expansion and self-renewal of CSCs. In vivo treatment of tumors with the Hedgehog inhibitor vismodegib reduce CAF and CSC expansion, resulting in an overall delay of tumor formation. Our results identify a novel intracellular signaling module that synergistically regulates CAFs and CSCs. Targeting CAFs with Hedgehog inhibitors may offer a novel therapeutic strategy against breast cancer. Cancer Res; 77(8); 2134-47. ©2017 AACR. ©2017 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28202523     DOI: 10.1158/0008-5472.CAN-15-3490

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  53 in total

1.  Cancer-associated fibroblasts promote colorectal cancer progression by secreting CLEC3B.

Authors:  Hui-Fang Zhu; Xu-Hui Zhang; Chuan-Sha Gu; Yan Zhong; Ting Long; Yi-Dan Ma; Zhi-Yan Hu; Zu-Guo Li; Xiao-Yan Wang
Journal:  Cancer Biol Ther       Date:  2019-03-20       Impact factor: 4.742

Review 2.  Targeting cancer stem cell pathways for cancer therapy.

Authors:  Liqun Yang; Pengfei Shi; Gaichao Zhao; Jie Xu; Wen Peng; Jiayi Zhang; Guanghui Zhang; Xiaowen Wang; Zhen Dong; Fei Chen; Hongjuan Cui
Journal:  Signal Transduct Target Ther       Date:  2020-02-07

Review 3.  Non-Coding RNAs as Regulators and Markers for Targeting of Breast Cancer and Cancer Stem Cells.

Authors:  Kirti S Prabhu; Afsheen Raza; Thasni Karedath; Syed Shadab Raza; Hamna Fathima; Eiman I Ahmed; Shilpa Kuttikrishnan; Lubna Therachiyil; Michal Kulinski; Said Dermime; Kulsoom Junejo; Martin Steinhoff; Shahab Uddin
Journal:  Cancers (Basel)       Date:  2020-02-04       Impact factor: 6.639

Review 4.  Mutual concessions and compromises between stromal cells and cancer cells: driving tumor development and drug resistance.

Authors:  Pritish Nilendu; Sachin C Sarode; Devashree Jahagirdar; Ishita Tandon; Shankargouda Patil; Gargi S Sarode; Jayanta K Pal; Nilesh Kumar Sharma
Journal:  Cell Oncol (Dordr)       Date:  2018-07-19       Impact factor: 6.730

Review 5.  Lung cancer stem cells-origin, characteristics and therapy.

Authors:  D Prabavathy; Y Swarnalatha; Niveditha Ramadoss
Journal:  Stem Cell Investig       Date:  2018-03-14

Review 6.  Therapeutic targeting of the crosstalk between cancer-associated fibroblasts and cancer stem cells.

Authors:  Tu-Xiong Huang; Xin-Yuan Guan; Li Fu
Journal:  Am J Cancer Res       Date:  2019-09-01       Impact factor: 6.166

7.  RUNX3 suppresses metastasis and stemness by inhibiting Hedgehog signaling in colorectal cancer.

Authors:  Bo Ram Kim; Yoo Jin Na; Jung Lim Kim; Yoon A Jeong; Seong Hye Park; Min Jee Jo; Soyeon Jeong; Sanghee Kang; Sang Cheul Oh; Dae-Hee Lee
Journal:  Cell Death Differ       Date:  2019-07-05       Impact factor: 15.828

8.  Open multi-culture platform for simple and flexible study of multi-cell type interactions.

Authors:  Yasmín R Álvarez-García; Karla P Ramos-Cruz; Reinaldo J Agostini-Infanzón; Loren E Stallcop; David J Beebe; Jay W Warrick; Maribella Domenech
Journal:  Lab Chip       Date:  2018-10-09       Impact factor: 6.799

Review 9.  Slow-cycling (dormant) cancer cells in therapy resistance, cancer relapse and metastasis.

Authors:  Sukanya Basu; Yang Dong; Rahul Kumar; Collene Jeter; Dean G Tang
Journal:  Semin Cancer Biol       Date:  2021-05-09       Impact factor: 15.707

Review 10.  Signaling pathways in cancer-associated fibroblasts and targeted therapy for cancer.

Authors:  Fanglong Wu; Jin Yang; Junjiang Liu; Ye Wang; Jingtian Mu; Qingxiang Zeng; Shuzhi Deng; Hongmei Zhou
Journal:  Signal Transduct Target Ther       Date:  2021-06-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.